ID	smiles	name	distance	standard deviation	matching rate (HMBC)		matching rate (HSQC)	
1	C\1(=C\[C@@H]2[C@H]3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(C)(C(C)O)O)/C	16α-(1', 2'-Dihydroxy-1'-methylpropyl)-eremantholide	0.09	0.79	5/33	15.15%	5/12	41.67%
2	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(O)(C(O)C)C)C(=C)C(=O)O2)/C	8α-(2`.3`dihydroxi-2`-methylbutanoyl)-15-deoxygoyazensolideo	0.33	1.00	6/31	19.35%	7/12	58.33%
3	[C@@H]1([C@@H]([C@H]2[C@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(C)C)OC(=O)C2=C)O)C	5β-Hydroxy-4.5.2'.3'tetrahydro-15-desoxygoyazensolide	0.10	0.76	3/30	10.00%	5/12	41.67%
4	[C@@H]1([C@@H]([C@H]2[C@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C1(C)C(O1)C)OC(=O)C2=C)O)C	 6α-(2'Methyl-2'. 3'-epoxybutyryloxy)-5'β-hydroxy-4(15)-goyazensanolide	0.10	0.74	4/34	11.76%	4/13	30.77%
5	[C@H]1(C[C@@H]2[C@@H]([C@@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C\C)/C)[C@H](C(=O)O2)C)C	4α.5-11α.13-Tetrahydro-15-deoxybudlein A.derivado semisintetico	0.05	0.67	10/35	28.57%	4/14	28.57%
6	[C@@H]1(C[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C/C)/C)[C@@H](C(=O)O2)C)C	(4S,6R,7S,8S,10R,11S)-1-Oxo-3,10-epoxy-8-angeloyloxygermacra-2-en-6(12)-olide	0.05	0.67	10/35	28.57%	4/14	28.57%
7	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C\C)/C)C(=C)C(=O)O2)/C	 lychnofolide 	0.30	0.91	9/31	29.03%	7/12	58.33%
8	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C/C)/C)C(=C)C(=O)O2)/C	6α-Tiglinoyloxy-goyazensolanolide	0.30	0.91	9/31	29.03%	7/12	58.33%
9	C\1(=C\[C@H]([C@H]2[C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C2=C)OCC(C)C)/C	2’,3’-Dihydro-15-desoxygoyazensolide	0.26	0.86	7/30	23.33%	3/12	25.00%
10	[C@@H]1([C@@H]([C@H]2[C@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)OC(=O)C2=C)O)C	5β-Hydroxy-4.5-dihydro-15-desoxygoyazensolide	0.08	0.63	4/32	12.50%	5/12	41.67%
11	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C1(C)C(C)O1)C(=C)C(=O)O2)/C	6α-[2.3-Epoxybuttyryloxy]-goyazensolide	0.37	0.90	6/32	18.75%	5/12	41.67%
12	[C@@H]1(C[C@@H]2[C@@H]([C@@H]([C@H]([C@@]3(C(=O)C=C1O3)C)O)OC(=O)CC(C)C)C(=C)C(=O)O2)C	4ß.5-Dihydro-9a-hydroxy-atripliciolide-8-0-isovalerate	0.16	0.68	8/32	25.00%	6/13	46.15%
13	C\1(=C\[C@@H]2C3[C@H](CC4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(CC)C)/C	eremantholide B	0.13	0.63	5/35	14.29%	4/13	30.77%
14	[C@H]1(C[C@@H]2[C@@H]([C@@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C\C)/C)[C@H](C(=O)O2)C)CO	4α.5-11α.13-Tetrahydrobudlein A.  derivado semisintetico	0.00	0.49	10/35	28.57%	4/14	28.57%
15	[C@H]1(C[C@@H]2[C@@H]([C@@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C\C)/C)[C@@H](C(=O)O2)C)CO	4α.5-11β.13-Tetrahydrobudlein A. derivado semisintetico	0.00	0.49	10/35	28.57%	4/14	28.57%
16	C\1(=C\[C@@H]2[C@H]3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)/C(=C/C)/C)/CO	15-Hydroxy-16α-(1-methylprop-1Z-enyl)-eremanthanolide	0.20	0.69	5/33	15.15%	5/12	41.67%
17	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)C(=C)C(=O)O2)/C	(3aR,4S,6R,11aR,Z)-6,10-dimethyl-3-methylene-2,7-dioxo-2,3,3a,4,5,6,7,11a-octahydro-6,9-epoxycyclodeca[b]furan-4-yl methacrylate	0.33	0.81	7/30	23.33%	6/11	54.55%
18	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)C(=C)C(=O)O2)/C	15-deoxygoyazensolide	0.33	0.81	7/30	23.33%	6/11	54.55%
19	C\1(=C\[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)/C(=C\C)/C)/C	(2aS,3R,4aS,6R,11aR,Z)-3-((Z)-but-2-en-2-yl)-3-hydroxy-2a,6,10-trimethyl-2a,3,4a,5,6,11a-hexahydro-2H-1,4,12-trioxa-6,9-methanocyclodeca[cd]pentalene-2,7(2a1H)-dione	0.15	0.63	4/33	12.12%	4/12	33.33%
20	C\1(=C\[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)/C(=C\C)/C)/C	16α-[1'Methylprop-1E-enyl]-eremantholanolide	0.15	0.63	4/33	12.12%	4/12	33.33%
21	C\1(=C\[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)/C(=C\C)/C)/C	16α-[1-Methylprop-1Z-enyl]-eremantholanolide	0.15	0.63	4/33	12.12%	4/12	33.33%
22	C\1(=C\[C@@H]2C3[C@H](CC4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(C)CC)/CO	15-hydroxyeremantholide B	0.20	0.66	5/35	14.29%	5/13	38.46%
23	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)O)[C@@H](C(=O)O2)C)/C	11β.13-dihydro-8α-hydroxy-goyazensanolide	0.00	0.46	4/27	14.81%	3/10	30.00%
24	C\1(=C\[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(OCC)/C(=C\C)/C)/CO	(2aS,3R,4aS,6R,11aR,Z)-3-((Z)-but-2-en-2-yl)-3-ethoxy-10-(hydroxymethyl)-2a,6-dimethyl-2a,3,4a,5,6,11a-hexahydro-2H-1,4,12-trioxa-6,9-methanocyclodeca[cd]pentalene-2,7(2a1H)-dione	0.28	0.73	4/34	11.76%	6/14	42.86%
25	C\1(=C\[C@@H]2[C@@H]([C@@H](CC3(C(=O)C=C1O3)C)OC(=O)C(=C)C)[C@](C(=O)O2)(O)CO)/C	11.13-Dihydroxy-calaxin	0.09	0.53	2/30	6.67%	4/11	36.36%
26	[C@H]1([C@@H]([C@@H]2[C@H]3[C@H](CC4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(C)C)O)C	(4R, 5S, 6S, 7S, 8S, 10R, 11S, 16R)-4,5-Dihydroeremantholide A	0.15	0.59	5/34	14.71%	5/13	38.46%
27	C\1(=C\[C@@H]2[C@@H]([C@@H]([C@H]([C@@]3(C(=O)C=C1O3)C)O)OC(=O)C(CC)C)C(=C)C(=O)O2)/C	9a-Hydroxy-atripliciolide-8-O-2-methylbutyrate	0.23	0.67	6/32	18.75%	4/13	30.77%
28	C\1(=C\[C@@H]2[C@H]3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(=C)C)/CO	15-Hydroxyeremantholide C 	0.25	0.68	3/32	9.38%	5/11	45.45%
29	C\1(=C\[C@@H]2[C@@H]([C@@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C\C)/C)C(=C)C(=O)O2)/CO	Budlein A	0.29	0.72	10/31	32.26%	7/12	58.33%
30	C\1(=C\[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(OCC)/C(=C\C)/C)/C	2aS,3R,4aS,6R,11aR,Z)-3-((Z)-but-2-en-2-yl)-3-ethoxy-2a,6,10-trimethyl-2a,3,4a,5,6,11a-hexahydro-2H-1,4,12-trioxa-6,9-methanocyclodeca[cd]pentalene-2,7(2a1H)-dione	0.24	0.66	2/34	5.88%	5/14	35.71%
31	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C\C)/C)C(=C)C(=O)O2)/CO	centratherin	0.29	0.71	9/31	29.03%	7/12	58.33%
32	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C\C)/C)C(=C)C(=O)O2)/CO	Lychnophorolide A	0.29	0.71	9/31	29.03%	7/12	58.33%
33	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C/C)/C)C(=C)C(=O)O2)/CO	Lychnophorolide B	0.29	0.71	9/31	29.03%	7/12	58.33%
34	C\1(=C\[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(OC)/C(=C\C)/C)/C	(2aS,3R,4aS,6R,11aR,Z)-3-((Z)-but-2-en-2-yl)-3-methoxy-2a,6,10-trimethyl-2a,3,4a,5,6,11a-hexahydro-2H-1,4,12-trioxa-6,9-methanocyclodeca[cd]pentalene-2,7(2a1H)-dione	0.25	0.66	2/34	5.88%	5/13	38.46%
35	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C1(C)CO1)C(=C)C(=O)O2)/C	2'.3'-Epoxy-15-deoxygoyazensolide  	0.38	0.79	6/31	19.35%	4/11	36.36%
36	C1(=C)[C@@H]([C@H](C2[C@H](CC3(C(=O)C=C1O3)C)O[C@]([C@@]2(C)C(=O)O)(O)C(C)CC)O)O	Dihydroxyacid	0.13	0.51	8/34	23.53%	5/13	38.46%
37	[C@@H]1(C[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(CO)(OC(=O)C)C)C(=C)C(=O)O2)C	(4S.6R.7S.8S.10R)-Oxo-3.10-epoxy-8-(2-acetoxy-3-hydroxypropanoyloxy)-germacra-2.11l( 13)-diene-6.12-olide  	0.17	0.53	4/32	12.50%	5/13	38.46%
38	C\1(=C\[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C1(C)C(O1)C)/C	16α-[1-Methyl-1,2-poxypropyl]-eremantholanolide	0.11	0.46	6/34	17.65%	2/12	16.67%
39	C\1(=C\[C@@H]2[C@H]3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C1(C(C)O1)C)/C	16α-(1'-Methyl-1,2-poxypropyl)-eremanthanolide	0.11	0.46	6/34	17.65%	2/12	16.67%
40	C\1(=C\[C@@H]2C3[C@H](CC4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(C)CC)/COC(=O)C	15-acetoxyeremantholide B	0.29	0.63	6/36	16.67%	3/14	21.43%
41	C\1(=C\[C@@H]2[C@@H]([C@@H]([C@H]([C@@]3(C(=O)C=C1O3)C)O)OC(=O)C(C)C)C(=C)C(=O)O2)/C	9a-Hydroxy-atripliciolide-8-O-isobutyrate 	0.29	0.63	4/28	14.29%	3/11	27.27%
42	[C@@H]1(C[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(CO)(O)C)C(=C)C(=O)O2)C	(4S.6R.7S.8S.10R)-1-0xo-3.10-epoxy-8-(2.3-dihydroxypropanoyloxy)-germacra-2.11(13)-dien-6.12-olide	0.19	0.53	5/32	15.62%	5/12	41.67%
43	[C@H]1(C[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C/C)/C)C(=C)C(=O)O2)C	(E)-(3aS,4S,6R,10R,11aR)-6,10-dimethyl-3-methylene-2,7-dioxo-2,3,3a,4,5,6,7,10,11,11a-decahydro-6,9-epoxycyclodeca[b]furan-4-yl 2-methylbut-2-enoate	0.18	0.51	9/33	27.27%	4/13	30.77%
44	[C@H]1(C[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C\C)/C)C(=C)C(=O)O2)C	(Z)-(3aS,4S,6R,10R,11aR)-6,10-dimethyl-3-methylene-2,7-dioxo-2,3,3a,4,5,6,7,10,11,11a-decahydro-6,9-epoxycyclodeca[b]furan-4-yl 2-methylbut-2-enoate	0.18	0.51	9/33	27.27%	4/13	30.77%
45	C1(C[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C/C)/C)C(=C)C(=O)O2)C	Tiglinoyloxy-zexbrevanolide 	0.18	0.51	9/33	27.27%	4/13	30.77%
46	[C@H]1(C[C@@H]2[C@@H]([C@@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C\C)/C)C(=C)C(=O)O2)CO	4α.5-Dihydrobudlein A.   derivado semisintetico	0.16	0.49	8/33	24.24%	5/13	38.46%
47	[C@@H]1(C[C@@H]2C([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C\C)/C)C(=C)C(=O)O2)C	8β-Angeloyloxy-zexbrevanolide 	0.19	0.51	8/33	24.24%	4/13	30.77%
48	[C@@H]1(C[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)/C(=C/C)/C)C	16α-[Methylprop-1 Z-enyI]-4β,5H-eremantholanolide	0.19	0.51	5/35	14.29%	4/13	30.77%
49	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)[C@H](C(=O)O2)CC)/C	11α.13-dihydro-13-methoxy-15-deoxygoyazensolide	0.01	0.31	5/34	14.71%	4/13	30.77%
50	[C@@H]1(C[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(COC(=O)C)(O)C)C(=C)C(=O)O2)C	(4S.6R.7S.8S.10R)-Oxo-3.10-epoxy-8-(3-acetoxy-2-hydroxypropanoyloxy)-germacra-2.11l( 13)-diene-6.12-olide  	0.21	0.50	5/33	15.15%	5/13	38.46%
51	C\1(=C\[C@@H]2[C@H]3[C@H](CC4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(C)C)/C	composto 5	0.17	0.46	3/33	9.09%	4/12	33.33%
52	C\1(=C\[C@@H]2C3[C@H](CC4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(C)C)/C	eremantholide A	0.17	0.46	3/33	9.09%	4/12	33.33%
53	[C@H]1(C[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(=C)C)C	(2aS,3R,4aS,6R,10R,11aR)-3-hydroxy-2a,6,10-trimethyl-3-(prop-1-en-2-yl)-2a,3,4a,5,6,10,11,11a-octahydro-2H-1,4,12-trioxa-6,9-methanocyclodeca[cd]pentalene-2,7(2a1H)-dione	0.24	0.50	4/34	11.76%	5/12	41.67%
54	[C@@H]1(C[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(=C)C)C	(4S,6R,7S,8S,10R,11lS,16R)-4,5-Dihydroeremantholide C 	0.24	0.50	4/34	11.76%	5/12	41.67%
55	[C@@H]1(C[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(=C)C)C	16α-Isopropenyl-4β,5H-eremantholanolide	0.24	0.50	4/34	11.76%	5/12	41.67%
56	[C@@H]1(C[C@@H]2[C@H]3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(OC)/C(=C\C)/C)C	(4S,6R,7S,8S,10R,11S,16R)-1-Oxo-3(10),8(16)-diepoxy-16-methylprop-1Z-enyl-16-methoxygermacra-2-en-6(12)-olide	0.28	0.54	6/36	16.67%	4/14	28.57%
57	[C@@H]1(C[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)[C@@]1(OC1)C)C	(4S,6R,7S,8S,10R,11S,16R,17R)-4,5-Dihydro-17,18-epoxyeremantholide C	0.19	0.42	3/35	8.57%	4/12	33.33%
58	C\1(=C\[C@@H]2[C@H]3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)/C(=C/C)/C)/COC(=O)C	((2aS,2a1R,3R,4aS,6R,11aR,Z)-3-((E)-but-2-en-2-yl)-3-hydroxy-2a,6-dimethyl-2,7-dioxo-2a,2a1,3,4a,5,6,7,11a-octahydro-2H-1,4,12-trioxa-6,9-methanocyclodeca[cd]pentalen-10-yl)methyl acetate	0.29	0.53	4/34	11.76%	2/13	15.38%
59	C\1(=C\[C@@H]2[C@H]3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)/C(=C\C)/C)/COC(=O)C	15-Acetoxy-16α-(1-methylprop-1Z-enyl)-eremanthanolide	0.29	0.53	4/34	11.76%	2/13	15.38%
60	[C@@H]1(C[C@@H]2[C@H]3[C@H](CC4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(C)C)C	(2aS,2a1R,3R,4aS,10S,11aR)-3-hydroxy-3-isopropyl-2a,6,10-trimethyl-2a,3,4a,5,6,10,11,11a-octahydro-2H-1,4,12-trioxa-6,9-methanocyclodeca[cd]pentalene-2,7(2a1H)-dione	0.19	0.42	3/34	8.82%	4/13	30.77%
61	[C@@H]1(C[C@@H]2C3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(C)C)C	16α-Isopropyl-4β,5H-eremantholanolide	0.19	0.42	3/34	8.82%	4/13	30.77%
62	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)C(=C)C(=O)O2)/CO	goyazensolide	0.35	0.56	6/30	20.00%	5/11	45.45%
63	C\1(=C\[C@@H]2[C@H]3[C@H](C[C@@]4(C(=O)C=C1O4)C)O[C@]([C@]3(C(=O)O2)C)(O)C(=C)C)/COC(=O)C	15-acetoxyeremantholide C 	0.35	0.50	3/33	9.09%	3/12	25.00%
64	C\1(=C\[C@H]2[C@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C/C)/CO)OC(=O)C2=C)/C	 6α-[5'-Hydroxytigloyloxy)-goyazensanolide	0.41	0.50	5/31	16.13%	5/12	41.67%
65	[C@@H]1(C[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C1(OC1)C)C(=C)C(=O)O2)C	(4S.6R.7S.8S.10R)-1-Oxo-3.10-epoxy-8-(2.3-epoxtypropanoyl-oxy)-germacra-2.11(13)-diene-6.12-oIide 	0.20	0.30	5/33	15.15%	3/12	25.00%
66	[C@H]1(C[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)C(=C)C(=O)O2)C	(3aS,4S,6R,10R,11aR)-6,10-dimethyl-3-methylene-2,7-dioxo-2,3,3a,4,5,6,7,10,11,11a-decahydro-6,9-epoxycyclodeca[b]furan-4-yl methacrylate	0.21	0.30	6/32	18.75%	3/12	25.00%
67	C1(C[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)C(=C)C(=O)O2)C	8α-[2-Methylacryloyloxy]-zexbrevanolide 	0.21	0.30	6/32	18.75%	3/12	25.00%
68	[C@@H]1(C[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)C(=C)C(=O)O2)C	(4S.6R.7S.8S.10R)-1-Oxo-3.10-epoxy-8-methacryloxygermacra-2.11(13)-dien-6.12-olide 	0.21	0.30	6/32	18.75%	3/12	25.00%
69	[C@H]1(C[C@@H]2[C@@H]([C@@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)C(=C)C(=O)O2)C	zexbrevin	0.22	0.30	5/32	15.62%	3/12	25.00%
70	C\1(=C\[C@H]2[C@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C(O)C)OC(=O)C2=C)/C	 6α-[2'-(1')-hydroxyethylacryloyloxyl]-goyazensanolide	0.45	0.47	5/31	16.13%	4/12	33.33%
71	C1(=C)[C@H]([C@H]([C@H]2[C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C2=C)OC(=O)/C(=C\C)/C)O	5α-Hydroxy-6α-angeloyloxy-Δ-4.15-isogoyazensanolide	0.28	0.28	6/31	19.35%	3/12	25.00%
72	C1(=C)[C@@H]([C@H]([C@H]2[C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C2=C)OC(=O)/C(=C\C)/C)O	5β-Hydroxy-6α-angeloyloxy-Δ-4.15-isogoyazensanolide	0.28	0.28	6/31	19.35%	3/12	25.00%
73	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)/C(=C\C)/C)C(=C)C(=O)O2)/COC(=O)C	1-Oxo-3.10-epoxy-8-angeloxy-15-acetoxygermacra-2.4.11(13)-trien-6(12)-oIide 	0.42	0.30	7/32	21.88%	5/13	38.46%
74	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)C(=C)C(=O)O2)/COC(=O)C	1-Oxo-3.10-epoxy-8-metacriloxy-15-acetoxygermacra-2.4.11(13)-trien-6(12)-oIide 	0.50	0.30	5/31	16.13%	3/12	25.00%
75	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)C(=C)C(=O)O2)/COC(=O)C	goyazensolide acetate	0.50	0.30	5/31	16.13%	3/12	25.00%
76	C1(=C)C[C@H](C2C(C[C@@]3(C(=O)C=C1O3)C)OC(=O)C2=C)OC(=O)C(=C)C	5β-Hydroxy-6α-methacryloyloxy-Δ4.15-iso-goyazensanolide	0.33	0.00	3/30	10.00%	3/11	27.27%
77	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C[C@H]1[C@H](C3=CC(=O)[C@@](C[C@@H]([C@@H]4[C@@H]1OC(=O)C4=C)OC(=O)C(=C)C)(O3)C)C)C(=C)C(=O)O2)/C	rufescenolide C 	1.00	0.66	4/67	5.97%	7/23	30.43%
78	C\1(=C\[C@@H]2[C@@H]([C@H](C[C@@]3([C@H](C[C@@H]1O3)O)CO)OC(=O)/C(=C\C)/C)C(=C)C(=O)O2)/C	(-)-8α-Angeloxy-3α.10α-epoxy-1α.14-dihydroxygermacra-Z4-(5).11(13)-dien-6α.12-olide (furanonobilin)	0.39	0.04	2/38	5.26%	5/14	35.71%
79	C1(=C)[C@@H]([C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)C(=C)C(=O)O2)OC(=O)C	(3aR,4S,6R,11S,11aS)-11-acetoxy-6-methyl-3,10-dimethylene-2,7-dioxo-2,3,3a,4,5,6,7,10,11,11a-decahydro-6,9-epoxycyclodeca[b]furan-4-yl methacrylate	0.37	0.01	4/31	12.90%	2/12	16.67%
80	C1(=C)[C@H]([C@@H]2[C@@H]([C@H](C[C@@]3(C(=O)C=C1O3)C)OC(=O)C(=C)C)C(=C)C(=O)O2)OC(=O)C	isogoyazensolide  acetate	0.37	0.01	4/31	12.90%	2/12	16.67%
